Development of framework for assessing influenza virus pandemic risk

Emerging Infectious Diseases

Volumn 21, Issue 8, 2015, Pages 1372-1378

  Trock, Susan C ^a   Burke, Stephen A ^a,b   Cox, Nancy J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONCEPTUAL FRAMEWORK; DISEASE SEVERITY; DISEASE TRANSMISSION; HUMAN; IMMUNITY; INFLUENZA VIRUS; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H7N9; NONHUMAN; PANDEMIC; PANDEMIC INFLUENZA; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; DEVICES; IMMUNOLOGY; INFLUENZA, HUMAN; MORTALITY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

HUMANS; INFLUENZA, HUMAN; PANDEMICS; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 84937468596     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2108.141086     Document Type: Article

References (18)

1. Iskander J, Strikas RA, Gensheimer KF, Cox NJ, Redd SC. Pandemic influenza planning, United States, 1978-2008. Emerg Infect Dis. 2013;19:879-85. http://dx.doi.org/10.3201/eid1906.121478
2. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58:400-2.
3. Sonnberg S, Webby RJ, Webster RG. Natural history of highly pathogenic avian influenza H5N1. Virus Res. 2013;178:63-77. http://dx.doi.org/10.1016/j.virusres.2013.05.009
4. World Health Organization. Human infection with influenza A(H7N9) virus in China. 2013 April 1 [cited 2015 Jun 10]. http://www.who.int/csr/don/2013_04_01/en/index.html
5. Parry J. H7N9 avian flu infects humans for the first time. BMJ. 2013;346:f2151. http://dx.doi.org/10.1136/bmj.f2151
6. Parkin, RT. Foundations and frameworks for microbial risk assessments. Prepared for the US Environmental Protection Agency National Center for Environmental Assessment. Washington: Center for Risk Science and Public Health, School of Public Health and Health Services, The George Washington University Medical Center. 2008.
7. Trock SC, Burke SA, Cox NJ. Development of an influenza virologic risk assessment tool. Avian Dis. 2012;56:1058-61. http://dx.doi.org/10.1637/10204-041412-ResNote.1
8. Dolan JG. Multi-criteria clinical decision support: a primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare. Patient. 2010;3:229-48. http://dx.doi.org/10.2165/11539470-000000000-00000
9. Phillips LD. A theory of requisite decision models. Acta Psychol. 1984;56:29-48. http://dx.doi.org/10.1016/0001-6918(84)90005-2
10. Edwards W, Barron FH. SMARTS and SMARTER: improved simple methods for multiattribute utility measurement. Organ Behav Hum Decis Process. 1994;60:306-25. http://dx.doi.org/ 10.1006/obhd.1994.1087
11. Lindstrom S, Garten R, Balish A, Shu B, Emery S, Berman L, et al. Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis. 2012;18:834-7.
12. Epperson S, Jhung M, Richards S, Quinlisk P, Ball L, Moll M, et al. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis. 2013;57(Suppl 1):S4-11. http://dx.doi.org/10.1093/cid/cit272
13. Skowronski DM, Janjua NZ, Serres GD, Purych D, Gilca V, Scheifele DW, et al. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis. 2012;206:1852-61. http://dx.doi.org/ 10.1093/infdis/jis500
14. Waalen K, Kilander A, Dudman SG, Ramos-Ocao R, Hungnes O. Age-dependent prevalence of antibodies cross-reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011. Euro Surveill. 2012;17:pii:20170. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20170.
15. Centers for Disease Control and Prevention. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of the 2010-11 seasonal influenza vaccine on cross-reactive antibodies-United States. MMWR Morb Mortal Wkly Rep. 2012;61:237-41.
16. Jhung MA, Epperson S, Biggerstaff M, Allen D, Balish A, Barnes N, et al. Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis. 2013;57:1703-12 10.1093/cid/cit649.
17. Centers for Disease Control and Prevention. Influenza A (H3N2) variant virus-related hospitalizations: Ohio, 2012. MMWR Morb Mortal Wkly Rep. 2012;61:764-7.
18. Reed C, Biggerstaff M, Finelli L, Koonini LM, Beauvais D, Uzicanin A, et al. Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics. Emerg Infect Dis. 2013;19:85-91.